Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Jun

Showing results (31-40 of 230) with videos related to

Pageof 23
Sort By:
Clinical Toxicology (Philadelphia, Pa.)|May 16, 2007
Potency of five structurally different acetylcholinesterase reactivators to reactivate human brain cholinesterases inhibited by cyclosarinKamil Kuca, Jiri Cabal, Daniel Jun, et al.
Journal of Chromatographic Science|September 8, 2010
High-performance liquid chromatography analysis of by-products and intermediates arising during the synthesis of the acetylcholinesterase reactivator HI-6Daniel Jun, Petr Stodulka, Kamil Kuca, et al.
International Journal of Toxicology|January 6, 2006
Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testingLucie Bartosova, Kamil Kuca, Daniel Jun, et al.
Neurotoxicity Research|April 24, 2007
In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterasesKamil Kuca, Jiri Cabal, Daniel Jun, et al.
Protein and Peptide Letters|October 16, 2008
Cholinesterase biosensor construction - a reviewMiroslav Pohanka, Daniel Jun, Huba Kalasz, et al.
Basic & Clinical Pharmacology & Toxicology|October 4, 2007
Comparison of reactivating and therapeutic efficacy of two salts of the oxime HI-6 against tabun, soman and cyclosarin in ratsJiri Kassa, Daniel Jun, Kamil Kuca, et al.
Journal of Applied Toxicology : JAT|November 25, 2005
Effect of some acetylcholinesterase reactivators on human platelet aggregation in vitroDaniel Jun, Kamil Kuca, Miloslav Hronek, et al.
Nature Neuroscience|January 12, 2016
KIF1A inhibition immortalizes brain stem cells but blocks BDNF-mediated neuronal migrationAurelie Carabalona, Daniel Jun-Kit Hu, Richard B Vallee
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|December 10, 2015
Outcomes After Cochlear Implantation in the Very ElderlyDaniel Jun Yi Wong, Michelle Moran, Stephen John O'Leary
Clinical Toxicology (Philadelphia, Pa.)|July 10, 2009
In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesteraseLucie Musilova, Kamil Kuca, Young-Sik Jung, et al.
Pageof 23

Showing results (31-40 of 230) with videos related to

Sort By:
Pageof 23
Clinical Toxicology (Philadelphia, Pa.)|May 16, 2007
Potency of five structurally different acetylcholinesterase reactivators to reactivate human brain cholinesterases inhibited by cyclosarinKamil Kuca, Jiri Cabal, Daniel Jun, et al.
Journal of Chromatographic Science|September 8, 2010
High-performance liquid chromatography analysis of by-products and intermediates arising during the synthesis of the acetylcholinesterase reactivator HI-6Daniel Jun, Petr Stodulka, Kamil Kuca, et al.
International Journal of Toxicology|January 6, 2006
Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testingLucie Bartosova, Kamil Kuca, Daniel Jun, et al.
Neurotoxicity Research|April 24, 2007
In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterasesKamil Kuca, Jiri Cabal, Daniel Jun, et al.
Protein and Peptide Letters|October 16, 2008
Cholinesterase biosensor construction - a reviewMiroslav Pohanka, Daniel Jun, Huba Kalasz, et al.
Basic & Clinical Pharmacology & Toxicology|October 4, 2007
Comparison of reactivating and therapeutic efficacy of two salts of the oxime HI-6 against tabun, soman and cyclosarin in ratsJiri Kassa, Daniel Jun, Kamil Kuca, et al.
Journal of Applied Toxicology : JAT|November 25, 2005
Effect of some acetylcholinesterase reactivators on human platelet aggregation in vitroDaniel Jun, Kamil Kuca, Miloslav Hronek, et al.
Nature Neuroscience|January 12, 2016
KIF1A inhibition immortalizes brain stem cells but blocks BDNF-mediated neuronal migrationAurelie Carabalona, Daniel Jun-Kit Hu, Richard B Vallee
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|December 10, 2015
Outcomes After Cochlear Implantation in the Very ElderlyDaniel Jun Yi Wong, Michelle Moran, Stephen John O'Leary
Clinical Toxicology (Philadelphia, Pa.)|July 10, 2009
In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesteraseLucie Musilova, Kamil Kuca, Young-Sik Jung, et al.
Pageof 23